title: Hydralazine and isosorbide dinitrate in heart failure: historical perspective, mechanisms, and future directions.
authors.affiliation: Emory University, Atlanta, GA 30322, USA.
authors.forename: Robert T
authors.initials: RT
authors.lastname: Cole
authors.forename: Andreas P
authors.initials: AP
authors.lastname: Kalogeropoulos
authors.forename: Vasiliki V
authors.initials: VV
authors.lastname: Georgiopoulou
authors.forename: Mihai
authors.initials: M
authors.lastname: Gheorghiade
authors.forename: Arshed
authors.initials: A
authors.lastname: Quyyumi
authors.forename: Clyde
authors.initials: C
authors.lastname: Yancy
authors.forename: Javed
authors.initials: J
authors.lastname: Butler
mesh_terms: D001741:Black or African American / Q000235:genetics; D000818:Animals; D017321:Clinical Trials, Phase I as Topic / Q000639:trends; D017322:Clinical Trials, Phase II as Topic / Q000639:trends; D017079:Exercise Tolerance / Q000187:drug effects / Q000502:physiology; D005544:Forecasting; D006333:Heart Failure / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D006801:Humans; D006830:Hydralazine / Q000494:pharmacology / Q000627:therapeutic use*; D007548:Isosorbide Dinitrate / Q000494:pharmacology / Q000627:therapeutic use*; D013318:Stroke Volume / Q000187:drug effects / Q000502:physiology
chemical_list: D006830:Hydralazine; D007548:Isosorbide Dinitrate